ConductScience.org, home

Paper17510707

Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.

Little CB and 6 others. J Clin Invest, 2007. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. Papers, record 17510707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17510707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.
PubMed
Journal
J Clin Invest
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
4.13
iCite
Revised in PubMed
2018-11-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Little CBChristopher B
2Meeker CTClare T
3Golub SBSuzanne B
4Lawlor KEKate E
5Farmer PJPamela J
6Smith SMSusan M
7Fosang AJAmanda J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AggrecansMajor topic
CartilageMajor topic
EndopeptidasesMajor topic
Animals
Arthritis, Experimental
Base Sequence
Binding Sites
DNA Primers
Female
Male
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Mutagenesis
Protein Structure, Tertiary
Recombinant Proteins

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115554875The ADAMTS metalloproteinases.Biochem J2005https://conductscience.org/library/papers/15554875PubMed
215798221Matrix metalloproteinases are not essential for aggrecan turnover during normal skeletal growth and development.Mol Cell Biol2005https://conductscience.org/library/papers/15798221PubMed
315800624Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.Nature2005https://conductscience.org/library/papers/15800624PubMed
415800625ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.Nature2005https://conductscience.org/library/papers/15800625PubMed
515880348ADAMTS-1-knockout mice do not exhibit abnormalities in aggrecan turnover in vitro or in vivo.Arthritis Rheum2005https://conductscience.org/library/papers/15880348PubMed
615987500ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.Arthritis Res Ther2005https://conductscience.org/library/papers/15987500PubMed
716146752MMPs and ADAMTSs: functional studies.Front Biosci2006https://conductscience.org/library/papers/16146752PubMed
816782710Shear and compression differentially regulate clusters of functionally related temporal transcription patterns in cartilage tissue.J Biol Chem2006https://conductscience.org/library/papers/16782710PubMed
916806997The cleavage of biglycan by aggrecanases.Osteoarthritis Cartilage2006https://conductscience.org/library/papers/16806997PubMed
1010542281Recombinant human aggrecan G1-G2 exhibits native binding properties and substrate specificity for matrix metalloproteinases and aggrecanase.J Biol Chem1999https://conductscience.org/library/papers/10542281PubMed
1110640399Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.Arch Biochem Biophys2000https://conductscience.org/library/papers/10640399PubMed
1210751421Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).J Biol Chem2000https://conductscience.org/library/papers/10751421PubMed
1310898492Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis.Eur J Immunol2000https://conductscience.org/library/papers/10898492PubMed
1410959819Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in the human.Histochem Cell Biol2000https://conductscience.org/library/papers/10959819PubMed
1510882746Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants.J Biol Chem2000https://conductscience.org/library/papers/10882746PubMed
1611032846
Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
J Biol Chem2000https://conductscience.org/library/papers/11032846PubMed
1710998358The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.Biochem J2000https://conductscience.org/library/papers/10998358PubMed
1811450222Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate. Analysis with fluorophore-assisted carbohydrate electrophoresis.Methods Mol Biol2001https://conductscience.org/library/papers/11450222PubMed
1911507769
Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.
Dev Dyn2001https://conductscience.org/library/papers/11507769PubMed
2011585439
Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.
J Med Chem2001https://conductscience.org/library/papers/11585439PubMed

See all 62 referencesDownload CSV of references

Cited by79

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
41925547Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease.FEBS J2026https://conductscience.org/library/papers/41925547PubMed
41917349An Overview of ADAMTS Proteases.Methods Mol Biol2026https://conductscience.org/library/papers/41917349PubMed
39600538Soluble Proteoglycans and Proteoglycan Fragments as Biomarkers of Pathological Extracellular Matrix Remodeling.Proteoglycan Res2024https://conductscience.org/library/papers/39600538PubMed
37235123Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats.Arch Rheumatol2023https://conductscience.org/library/papers/37235123PubMed
36474987Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum.Osteoarthr Cartil Open2021https://conductscience.org/library/papers/36474987PubMed
35913086The adaptive response of the mandibular condyle to increased load is disrupted by ADAMTS5 deficiency.Connect Tissue Res2023https://conductscience.org/library/papers/35913086PubMed
35883515The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis.Biomolecules2022https://conductscience.org/library/papers/35883515PubMed
35196167Methods for isolating and analyzing physiological hyaluronan: a review.Am J Physiol Cell Physiol2022https://conductscience.org/library/papers/35196167PubMed
35168639Elevation of MMP1 and ADAMTS5 mRNA expression in glenohumeral synovia of patients with hypercholesterolemia.J Orthop Surg Res2022https://conductscience.org/library/papers/35168639PubMed
34652292Blood and urine biomarkers in osteoarthritis - an update on cartilage associated type II collagen and aggrecan markers.Curr Opin Rheumatol2022https://conductscience.org/library/papers/34652292PubMed
34575579Hyaluronic Acid-Binding, Anionic, Nanoparticles Inhibit ECM Degradation and Restore Compressive Stiffness in Aggrecan-Depleted Articular Cartilage Explants.Pharmaceutics2021https://conductscience.org/library/papers/34575579PubMed
34434966ADAMTS5 in Osteoarthritis: Biological Functions, Regulatory Network, and Potential Targeting Therapies.Front Mol Biosci2021https://conductscience.org/library/papers/34434966PubMed
34195596
A new mouse mutant with cleavage-resistant versican and isoform-specific versican mutants demonstrate that proteolysis at the Glu441-Ala442 peptide bond in the V1 isoform is essential for interdigital web regression.
Matrix Biol Plus2021https://conductscience.org/library/papers/34195596PubMed
33804223Hyalectanase Activities by the ADAMTS Metalloproteases.Int J Mol Sci2021https://conductscience.org/library/papers/33804223PubMed
33800057From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside.Int J Mol Sci2021https://conductscience.org/library/papers/33800057PubMed
33718860ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies.Matrix Biol Plus2021https://conductscience.org/library/papers/33718860PubMed
33482899Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis.Arthritis Res Ther2021https://conductscience.org/library/papers/33482899PubMed
33441904Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide.Sci Rep2021https://conductscience.org/library/papers/33441904PubMed
33063247Novel Analgesics with Peripheral Targets.Neurotherapeutics2020https://conductscience.org/library/papers/33063247PubMed
32875613The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.Dev Dyn2021https://conductscience.org/library/papers/32875613PubMed

See all 79 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17510707

GET https://conductscience.org/api/papers/v1/17510707/references?page=2